Research peptides for Europe.For research use only
500 mgNAD+ 500 mg vial, packaging concept

Mitochondrial research

NAD+

500 mg · Lyophilised powder

Read product FAQs

Ordering opens later. Prices and availability are not yet published.

Ordering opens later. Prices and availability are not yet published.

Certificate of analysis

Batch 100256 · Janoshik #230357

Analysed 15 September 2026. Component amounts are shown in the report; no overall purity is stated.

Original report client: Peptide Central UK.
Verification key: BMWZESPKDPMA

NAD+ 500 mg, supplied as lyophilised powder in a sealed, labelled vial for in-vitro laboratory research.

⚠ For laboratory research only. Not for use in or on humans or animals.

Specification

Compound
NAD+
Labelled amount
500 mg
Form
Lyophilised powder
Research area
Mitochondrial research
Label specification
≥99% purity (ordering specification)
Batch report
Janoshik #230357
Batch number
100256
Reported purity
Not stated
Analysis date
15 September 2026
Storage
Stated with each batch

Images are packaging concepts, not photographed inventory.

Product FAQs

Questions about NAD+ 500 mg, its specification and documentation.

All EPS FAQs

About the material

What is NAD+ 500 mg, and is NAD+ a peptide?

NAD+ means oxidised nicotinamide adenine dinucleotide, a coenzyme. It is not an amino-acid peptide. The 500 mg entry describes a labelled amount of research material.

Are NAD+, NMN and NR the same compound?

NMN and NR are distinct molecules involved in NAD metabolism. They are not alternate names for NAD+. Read the NAD+, NMN and NR comparison.

Is this NAD+ vial a supplement or pharmacy-prepared infusion?

This EPS listing describes research material. A supplement or pharmacy preparation has its own formulation and intended use; a shared compound name does not establish equivalence.

Does every NAD+ report include a purity percentage?

Read the original tests. A report may state a quantitative amount without a chromatographic purity result. An unstated percentage must not be inferred from the nominal vial size or another product report.

Vial amounts and testing

What does the NAD+ 500 mg label measure?

500 mg identifies the nominal mass of material per vial. It does not specify a dose, a concentration in mg/mL or a measured-content result. Concentration additionally requires a defined final solution volume.

Where is the certificate of analysis for NAD+ 500 mg?

This page links Janoshik report #230357, an original source report naming Peptide Central UK as its client. The reported batch is 100256. This documents the submitted sample, not a verified connection to current EPS inventory. The COA library retains the original document and verification details.

How do I check whether a NAD+ COA matches my vial?

Compare the compound, chemical form, vial amount, sample description and batch or lot number. Verify the report through the issuing laboratory using its identifier and key. Use the COA verification checklist.

Does a NAD+ purity result verify content, sterility or endotoxins?

Check which results the original report actually provides. A purity percentage does not quantify milligrams per vial or establish sterility and endotoxin results. Those require their own stated tests. The label's ordering specification is not a measured batch result.

Ordering and handling

What is the price and availability of NAD+ 500 mg at EPS?

Use the purchase section on this page for the current EPS listing status. A displayed sample price or preview basket does not establish live inventory or a confirmed order. Where the page says Price at launch, no selling price has been confirmed. Contact EPS for product enquiries.

How do I compare NAD+ 500 mg prices per mg?

Divide the current single-vial price by 500 for cost per labelled mg. Include shipping and compare the same chemical form and documentation. An unpriced size cannot establish a lowest-cost option.

How should NAD+ 500 mg be stored?

Follow verified storage instructions for the exact supplied material and batch. Storage of dry powder and a prepared solution are separate questions. A general temperature range or preservative does not establish stability or an expiry. Read the storage and stability record guide.

How should NAD+ 500 mg be reconstituted for laboratory research?

Use a procedure validated for the exact chemical form and intended assay. Confirm solvent compatibility, concentration, container capacity and stability evidence; no universal diluent or shelf life is established here. Read the laboratory preparation guide. EPS does not provide administration or dosing instructions.

Where does EPS ship NAD+ 500 mg, and when will it dispatch?

EPS delivery destinations, dispatch origin, rates and times must be confirmed in the shipping information before orders open. A country page or catalogue listing is not a delivery guarantee. Dispatch promises from another retailer do not apply to EPS.

What should I do if my NAD+ 500 mg vial arrives damaged?

Keep the packaging and label, photograph the damage and contact EPS with the order and batch details. Read the EPS returns and withdrawal information for the applicable process and rights. Another retailer's return deadlines do not define EPS terms.

What is the permitted use of NAD+ 500 mg?

NAD+ 500 mg is listed for lawful in-vitro laboratory research as research material. It is not supplied for use in or on humans or animals. EPS does not provide dosing or self-administration guidance. Read the research use statement and assess the requirements that apply to the intended laboratory work.